Eggnovo
Eggnovo S.L. is a Spanish biotechnology company that manufactures patented, branded functional ingredients from eggshell membrane and shell via a circular-economy process, supplying nutraceutical, cosmetic, food & beverage, pet nutrition, and industrial manufacturers across 50+ countries.
- Company typePrivate
- Founded2012
- HeadquartersVillatuerta, Spain
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Eggnovo does
Eggnovo S.L. is a Spanish biotechnology company founded in 2012 in Villatuerta, Navarra, that manufactures branded functional ingredients derived from eggshell membrane and eggshell through a patented circular-economy process. The company extracts and preserves a matrix of naturally occurring bioactive compounds — including collagen types I, V and X, hyaluronic acid, elastin, chondroitin sulphate, glucosamine, and over 400 biomolecules — and converts eggshell calcium into a multimineral matrix and an upcycled industrial calcium carbonate. The proprietary portfolio comprises seven trademarked ingredients: Ovomet (joint health and mobility), Ovoderm (skin, hair, nail beauty-from-within), Ovocet (bone health), Ovopet (pet health), RejuveColl Triple Active and Mineralsens (cosmetics), and Circular Carb (industrial fillers for plastics, rubber, paints and ceramics).
Eggnovo operates a sales-led B2B ingredients model, supplying formulators and manufacturers in the nutraceutical, food & beverage, cosmetic, pet nutrition, and industrial sectors across more than 50 countries. Manufacturing is centralized at a single facility in Villatuerta, with commercial offices in Spain (Tajonar) and France supporting international customer engagement. The company offers galenic-format variants (capsules, softgels, vials, powders, tablets, gummies, liquid shots) for compatibility with diverse supplement and food matrices, and substantiates efficacy with over 20 in vivo, in vitro, and clinical studies. FSSC 22000 and Halal certifications position the platform for global food, supplement, and Middle East/Asia distribution.
Revenue mechanics are based on direct B2B ingredient sales to enterprise manufacturers at quote-based, undisclosed pricing. The company reported revenue above €10 million in 2025, with 30%+ annual growth between 2020 and 2025. In March 2026, Aleos Capital acquired a majority stake through its inaugural fund Aleos Fund I — with participation from an international sector-experienced investor — to fund expansion into Asia and the United States and to develop new applications in cosmetics, food & beverages, and eco-industrial solutions. The company employs 40 people as of 2025.
Eggnovo firmographics
Firmographics- Name
- Eggnovo
- Legal name
- EGGNOVO S.L.
- Website
- https://eggnovo.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Eggnovo S.L. is a Spanish biotechnology company that manufactures patented, branded functional ingredients from eggshell membrane and shell via a circular-economy process, supplying nutraceutical, cosmetic, food & beverage, pet nutrition, and industrial manufacturers across 50+ countries.
- Ownership category
- akta.pro rank
Eggnovo industry classification
Industry- Product category
- Nutraceutical ingredients
- NAICS
- Food Manufacturing (311)
- SIC
- Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090)
- akta.pro primary industry
- Egg ingredient manufacturing (albumen, yolk solids, egg protein isolates/hydrolysates) (AFANAHAG)
- akta.pro secondary industries
- Eggs & Egg Products (Shell, Liquid, Value-Added) (CRADACAJ), Value-Added Egg Products (Hard-Boiled, Omelets, Egg Mixes) Wholesale (AFAIAEAH)
Keywords
Where Eggnovo is headquartered
LocationHeadquarters
- HQ city
- Villatuerta
- HQ country
- Spain
- HQ region
- Europe
Offices3 records
Markets served
Eggnovo business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Technology or R&D, Personnel, Supply Chain, Marketing or Sales
Revenue model
- B2B Ingredient Sales: Eggnovo generates revenue by selling its branded functional ingredients (OVOMET, OVODERM, OVOCET, OVOPET, RejuveColl, Circular Carb) to nutraceutical, cosmetic, food & beverage, pet nutrition, and industrial manufacturers. The company operates on a B2B model supplying raw materials for dietary supplements, functional foods, cosmetics, and industrial applications.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Eggnovo product offering
Product offeringCore offering
Eggnovo manufactures and sells branded functional ingredients extracted from eggshell membrane and shells through a patented circular economy process. Its portfolio — including OVOMET (joint health), OVODERM (skin/hair/nail), OVOCET (bone health), OVOPET (pet health), RejuveColl and Mineralsens (cosmetics), and Circular Carb (industrial) — is supplied B2B to nutraceutical, food & beverage, cosmetic, pet nutrition, and industrial manufacturers in over 50 countries.
Product overview
Eggnovo is a biotechnology company that develops and manufactures natural functional ingredients extracted from eggshell membranes and shells through a circular economy model. Their portfolio includes branded ingredients for the nutraceutical, cosmetic, food & beverage, pet nutrition, and industrial sectors. Core products include Ovomet® (vegetarian collagen for joint health and mobility), Ovoderm® (beauty-from-within collagen for skin, hair, and nails), Ovocet® (calcium multimineral matrix for bone health), and Ovopet® (eggshell membrane for pet health). Cosmetic offerings comprise RejuveColl™ – Triple Active (skin rejuvenation ingredient) and Mineralsens™ (calcium carbonate for cosmetics). Industrial applications are served through Circular Carb™ (bio-based calcium carbonate filler for plastics, rubber, paints, and ceramics). All ingredients are science-backed with over 20 in vivo, in vitro, and clinical studies and are produced through a patented, 100% renewable, zero-waste process.
Differentiator
Problem solved
Functional benefit
Products and services
- OVOMET® Natural vegetarian collagen type I, V & X sourced from eggshell membrane, designed to support joint health and mobility with a 300mg daily dose. Contains hyaluronic acid, elastin, chondroitin sulphate, and glucosamine. Sold B2B to nutraceutical and supplement manufacturers.
- OVODERM® Natural vegetarian collagen type I, V & X from eggshell membrane formulated for hair, nails, and skin health with a 300mg daily dose. Contains hyaluronic acid and elastin for skin elasticity and hydration. Sold B2B to nutraceutical and supplement manufacturers.
- OVOCET® Natural and upcycled calcium multimineral matrix from eggshell containing calcium carbonate, strontium, magnesium, phosphorus, zinc, and soluble transport proteins. Highly bioavailable source for bone, muscle, and teeth health. Sold B2B to nutraceutical and supplement manufacturers.
- OVOPET® Natural eggshell membrane ingredient for pet health containing collagen, hyaluronic acid, elastin, chondroitin sulphate, and glucosamine among 400 biomolecules. Supports joint, skin, and gut health in dogs, cats, and horses. Sold B2B to pet nutrition and animal health manufacturers in formats including supplements, treats, powders, tablets, capsules, dry & wet food, pellets, and soft chews.
- RejuveColl™ – Triple Active Natural cosmetic ingredient derived from eggshell membrane containing collagen and elastin peptides, hyaluronic acid, and over 400 biomolecules. Provides holistic skin rejuvenation, barrier restoration, and anti-aging benefits at 1-5% concentration. Sold B2B to cosmetics and personal care brands for use in toners, masks, hair lotions, serums, and creams.
- Mineralsens™ High-purity calcium carbonate ingredient for cosmetic formulations derived from eggshells. Sold B2B to cosmetics and personal care brands.
- Circular Carb™ Sustainable bio-based calcium carbonate filler from upcycled eggshells for industrial applications including plastics, rubber, paints, coatings, and ceramics. Produced through patented circular economy processes with low carbon footprint, compatible with different plastic matrixes and improving mechanical, thermal, and processing properties. Sold B2B to industrial materials manufacturers.
Quantifiable outcome
- 300mg daily dose of OVOMET demonstrates significant reduction in joint pain and stiffness within 5 days
- +2 more outcomes
Companies that use Eggnovo
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles5 records
Eggnovo technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Eggnovo partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- United Nations (SDG Alignment)minorEggnovo aligns with the UN 2030 Sustainable Development Goals (SDGs), contributing to strategic areas within the SDG framework including responsible consumption and production, good health and well-being, and other sustainability objectives through its circular economy operations and upcycled ingredient business model.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Eggnovo competitors and assessment
Company assessmentDirect peers
- Biova: US-based supplier of water-soluble eggshell membrane ingredients for joint, skin, and animal health applications. Direct competitor in the eggshell membrane ingredient category with overlapping product positioning (joint health, beauty) and a similar B2B ingredient-supply model.
- Stratum Nutrition (ESM Technologies): Markets NEM® (Natural Eggshell Membrane), a branded eggshell membrane ingredient for joint and connective tissue health sold to supplement manufacturers. Closest US-based direct peer with shared ingredient category, clinical-study-backed claims, and B2B nutraceutical customers.
- Bioiberica: Spanish-based life-science company producing bioactive ingredients for joint health, mobility, and animal nutrition from natural sources. Iberian peer with overlapping joint-health ingredient portfolio and B2B nutraceutical/pet-nutrition customer base.
Broad incumbents
- GELITA: Global leader in collagen peptides and gelatin for nutraceutical, food, and pharmaceutical applications. Serves the same supplement and functional-food formulators that Eggnovo targets, with much broader portfolio and deeper distribution.
- Rousselot: World-leading gelatin and collagen peptide manufacturer owned by Darling Ingredients. Competes head-to-head with Eggnovo in collagen-positioned ingredients for nutraceutical and food applications, with far greater scale and global reach.
- PB Leiner: Part of Tessenderlo Group, producing gelatin, collagen peptides, and related functional ingredients for food, nutraceutical, and pet nutrition. Overlaps with Eggnovo's collagen, pet nutrition, and food & beverage verticals.
- Vital Proteins: Leading consumer collagen and wellness supplement brand. Although a finished-product brand rather than an ingredient supplier, it defines the market Eggnovo's nutraceutical customers serve and shapes competitive positioning across beauty-from-within and joint health categories.
- Seppic: Air Liquide subsidiary supplying specialty ingredients for cosmetics, nutrition, and pharma. Overlaps with Eggnovo's RejuveColl and Mineralsens cosmetic ingredient offerings and serves the same beauty and personal care formulators.
- Tessenderlo Group: Belgian specialty group whose PB Leiner division competes in collagen and gelatin ingredients for food, nutrition, and pet applications. Comparable as a diversified specialty ingredient platform with broader scale than Eggnovo.
Emerging players
- Specnova: Ingredient supplier specializing in egg-based and shell-membrane ingredients for joint and connective tissue health. Niche competitor with similar upstream feedstock and product positioning, focused on the supplement channel.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Eggnovo social profiles
Digital presenceEggnovo compliance and trust
Trust signalCompliance2 records
Eggnovo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Eggnovo leadership team
Management profileNumber of profiles
Profiles1 record
Eggnovo funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Eggnovo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Eggnovo
What does Eggnovo do?
Eggnovo manufactures and sells branded functional ingredients extracted from eggshell membrane and shells through a patented circular economy process. Its portfolio — including OVOMET (joint health), OVODERM (skin/hair/nail), OVOCET (bone health), OVOPET (pet health), RejuveColl and Mineralsens (cosmetics), and Circular Carb (industrial) — is supplied B2B to nutraceutical, food & beverage, cosmetic, pet nutrition, and industrial manufacturers in over 50 countries.
Is Eggnovo a public or private company?
Eggnovo is a private company. It is classified as private equity controlled and is currently operating.
When was Eggnovo founded?
Eggnovo was founded in 2012. It employs 11 to 50 people.
Where is Eggnovo based?
Eggnovo is headquartered in Villatuerta, Spain, in the Europe region.
How does Eggnovo make money?
One revenue line is on record: B2B Ingredient Sales.
Who are Eggnovo's main competitors?
Direct peers on record are Biova, Stratum Nutrition (ESM Technologies) and Bioiberica. Broad incumbents are GELITA, Rousselot, PB Leiner, Vital Proteins, Seppic and Tessenderlo Group. Specnova is listed as an emerging player.
Does Eggnovo have an API?
No public API is recorded for Eggnovo.
What industry is Eggnovo in?
Eggnovo's product category is Nutraceutical ingredients. Its primary akta.pro industry code is AFANAHAG, Egg ingredient manufacturing (albumen, yolk solids, egg protein isolates/hydrolysates), with a secondary code of CRADACAJ, Eggs & Egg Products (Shell, Liquid, Value-Added). Its NAICS code is 311 and its SIC code is 2000.